Blue Owl Capital Holdings LP Ovid Therapeutics Inc. Transaction History
Blue Owl Capital Holdings LP
- $377 Million
- Q1 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 864,822 shares of OVID stock, worth $665,912. This represents 0.7% of its overall portfolio holdings.
Number of Shares
864,822
Previous 864,822
-0.0%
Holding current value
$665,912
Previous $2.78 Million
5.28%
% of portfolio
0.7%
Previous 0.7%
Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
43.2MCall Options Held
5.9KPut Options Held
300-
Eco R1 Capital, LLC San Francisco, CA6.12MShares$4.71 Million0.53% of portfolio
-
Rubric Capital Management LP New York, NY5.32MShares$4.09 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.2MShares$3.23 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.97 Million0.35% of portfolio
-
Madison Avenue Partners, LP New York, NY3.65MShares$2.81 Million2.22% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $54.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...